1,1,1-trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo [2,3-C]pyridin-2-ylmethyl)pentan-2-ol Derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes.
A Standard patent application filed on 22 September 2004 credited to Hammach, Abdelhakim
;
Bekkali, Younes
;
Thomson, David S.
;
Riether, Doris
;
Harcken, Hanke Justus Joachim
;
Takahashi, Hidenori
;
Razavi, Hossein
;
Wang, Ji
;
Proudfoot, John Robert
;
Emmanuel, Michael J.
;
Liu, Pingrong
Details
Application number :
2004275757
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
1,1,1-trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo [2,3-C]pyridin-2-ylmethyl)pentan-2-ol Derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes.
Inventor :
Hammach, Abdelhakim
;
Bekkali, Younes
;
Thomson, David S.
;
Riether, Doris
;
Harcken, Hanke Justus Joachim
;
Takahashi, Hidenori
;
Razavi, Hossein
;
Wang, Ji
;
Proudfoot, John Robert
;
Emmanuel, Michael J.
;
Liu, Pingrong
Agent name :
Davies Collison Cave
Address for service :
1 Nicholson Street Melbourne VIC 3000 Australia
Filing date :
22 September 2004
Associated companies :
Applicant name :
Boehringer Ingelheim Pharmaceuticals, Inc.
Applicant address :
900 Ridgebury Road P.O. Box 368 Ridgefield CT 06877-0368 United States of America